Benzinga | Jan 28, 2022 09:04AM EST

ENVI Announces Quorum To Pass Business Combination With GreenLight Biosciences And Achievement Of All Transaction Requirements Following The Redemption Deadline

Upon consummation of the business combination, the ENVI ticker will transition to "GRNA" and is expected to start trading on the Nasdaq on February 3, 2022

BOSTON, Jan. 28, 2022 /PRNewswire/ -- Environmental Impact Acquisition Corporation ("ENVI" or the "Company") (NASDAQ:ENVI) today announced that it had achieved a quorum for the special meeting of its shareholders to be held on February 1, 2022 (the "Special Meeting"), in connection with its business combination with GreenLight Biosciences Inc. ("GreenLight"), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture.



ENVI's shareholders who have submitted proxies to date on the proposals included in the Company's proxy statement/prospectus for the Special Meeting have overwhelmingly voted in support of the business combination and all other proposals to be voted on at the meeting. Accordingly, it is anticipated that the business combination and the other proposals will be approved at the Special Meeting. However, shareholders may change or revoke their proxies before or at the Special Meeting.

The business combination, if approved by ENVI shareholders, is expected to close on February 2, 2022. Upon the closing of the business combination, common stock and warrants of the combined company are expected to begin trading on February 3, 2022, on Nasdaq under the ticker symbol GRNA.